---
layout: post
title: "Prospective Grant of an Exclusive Patent License: Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy; Correction"
date: 2026-02-05 19:08:48 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-05272
original_published: 2021-03-15 00:00:00 +0000
significance: 8.00
---

# Prospective Grant of an Exclusive Patent License: Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy; Correction

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 15, 2021 00:00 UTC
**Document Number:** 2021-05272

## Summary

The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on February 25, 2021. That Notice requires a correction in the SUPPLEMENTARY INFORMATION section.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/03/15/2021-05272/prospective-grant-of-an-exclusive-patent-license-engineered-tumor-infiltrating-lymphocytes-for)
- API: https://www.federalregister.gov/api/v1/documents/2021-05272

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
